These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium.
    Author: Botte L, Gilles C, Evrard JL, Mesters P, Wolfrum C, Berger M, Hellstern K, Ward J.
    Journal: Acta Psychiatr Scand Suppl; 1990; 360():42. PubMed ID: 2248066.
    Abstract:
    Moclobemide was compared with placebo for antidepressant activity, tolerance and safety in 2 parallel groups of 23 and 24 depressed patients. At the end of treatment (4 weeks or longer), 9 patients on moclobemide (41%) showed an improvement greater than or equal to 50% on the Hamilton Rating Scale for Depression, compared with only 4 (17%) of those on placebo. The overall assessment of efficacy was significantly better for moclobemide (good or very good results in 50% of patients) than for placebo (80% poor results). Moclobemide was well or very well tolerated by 85% of patients and placebo by 100%. Moclobemide was thus shown to be clearly more effective than placebo and only slightly less well tolerated.
    [Abstract] [Full Text] [Related] [New Search]